Anticoagulant properties of the electrophoresis of pyrazolone preparations in ischemic heart disease
Dizhenina, I.I.
Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 3: 47-50
1983
ISSN/ISBN: 0042-8787 PMID: 6623978 Document Number: 203875
Document emailed within 1 workday
Related Documents
Kaem, G.R. 1975: Importance of long-term anticoagulant therapy in ischemic heart disease Terapevticheskii Arkhiv 47(10): 124-131Guliamov, K.G. 1974: Effect of anticoagulant therapy on vascular permeability in patients with ischemic heart disease Terapevticheskii Arkhiv 46(9): 75-80
Belenkov, Y.N.; SHakaryants, G.A.; Khabarova, N.V. 2018: Tactics of Selection of Anticoagulant Therapy in Patients With Atrial Fibrillation and Ischemic Heart Disease Kardiologiia 2018(3): 43-52
Miterev, I.G.; Kubantseva, I.V.; Voronina, L.N.; Solov'eva, T.I.; Ivanova, A.N. 1985: Use of acetylsalicylic acid and dextran preparations in the treatment of ischemic heart disease Sovetskaia Meditsina 9: 74-79
Kazakov, I.M. 1981: Effect of antioxidants on the rheological and electrokinetic properties at the blood in ischemic heart disease Kardiologiia 21(8): 110-111
Furkalo, N.K.; Ivashchenko, T.I.; Bol'shakova, R.M.; Progonnaia, V.V.; Romanenko, A.I. 1982: Factors and mechanisms affecting the rheological properties of the blood in ischemic heart disease Terapevticheskii Arkhiv 54(11): 119-123
Liusov, V.A.; Belousov, I.B. 1977: Role of hemostasis and rheographic properties of blood in pathogenesis of ischemic heart disease Kardiologiia 17(5): 8-13
Progonnaia, V.V.; Romanenko, A.I. 1982: Erythrocyte electrophoretic mobility and the blood rheological properties in chronic ischemic heart disease Vrachebnoe Delo 4: 39-42
Parfenov, A.S.; Belousov, I.B. 1989: Relation between disorders of the rheological properties of the blood and the system of hemostasis in patients with ischemic heart disease Kardiologiia 29(10): 47-50
Torkhovskaia, T.I.; Gorbatenkova, E.A.; Dudaev, V.A.; Chesnokova, I.M.; Azizova, O.A. 1986: Cholesterol-acceptor properties of high-density lipoproteins with respect to erythrocyte membranes in patients with ischemic heart disease Voprosy Meditsinskoi Khimii 32(2): 101-105
Górniak, H. 1974: Determination of Co(II) in pharmaceutical preparations by means of 1-thiocarbamoyl-3-methyl-5-pyrazolone Acta Poloniae Pharmaceutica 31(4): 473-479
Liusov, V.A.; Gorbachenkov, A.A.; Dudaev, V.A.; Gorin, V.V. 1992: The effect of bee honey and flower pollen on the tolerance for physical loads, on lipid metabolism and on the rheological properties of the blood in patients with ischemic heart disease Kardiologiia 32(7-8): 45-48
Golikov, P.P.; Nikolaeva, N.I.; Kladiev, A.A. 1989: The activation of specific type-IIi glucocorticoid receptors by pyrazolone series preparations Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 4: 19-22
Weber, K.T.; Janicki, J.S.; Walker, A.A.; Kirklin, J.W. 1972: An assessment of intra-aortic balloon pumping in hypovolemic and ischemic heart preparations Journal of Thoracic and Cardiovascular Surgery 64(6): 869-877
Amosov, N.M.; Knyshov, G.V.; Mintser, O.P.; Ugarov, B.N.; Kononenko, I.N. 1982: Dynamics of cardiac minute volume in the diagnosis of heart failure in acquired heart defects and ischemic heart disease in the postoperative period Kardiologiia 22(10): 21-23
Koroleva, E.I.; Bulgadaeva, S.A.; Grigorovich, I.A. 1979: Some properties of partially purified preparations of cAMP phosphodiesterase from beef heart Biokhimiia 44(3): 555-563
Pietroiusti, A. 2002: Role of CagA positive Helicobacter pylori strains in ischemic heart disease and in ischemic stroke Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 3(11): 626-628
Loeliger, E.A. 1970: The dilemma of anticoagulant therapy in coronary heart disease Nederlands Tijdschrift Voor Geneeskunde 114(19): 810-813
Visser, J. 1970: The dilemma of anticoagulant therapy in coronary heart disease Nederlands Tijdschrift Voor Geneeskunde 114(29): 1221-1223
Pribylov, S.A. 2006: Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease Kardiologiia 46(9): 36-40